Literature DB >> 18201370

Peripheral blood CD14high CD16+ monocytes are main producers of IL-10.

J Skrzeczyńska-Moncznik1, M Bzowska, S Loseke, E Grage-Griebenow, M Zembala, J Pryjma.   

Abstract

Based on CD14 and CD16 expression, human peripheral blood monocytes (MO) can be divided into a major CD14(high) CD16(-) population and two minor CD14(high) CD16(+) and CD14(dim) CD16(+) subpopulations. CD14(dim) CD16(+) MO are well characterized and regarded as pro-inflammatory because upon stimulation produce TNF-alpha but little, if any, IL-10. By contrast, little is known about CD14(high) CD16(+) MO. We investigated the surface expression of selected determinants by CD16(+) MO subpopulations, cytokine production, phagocytosis and antigen presentation. We found that both CD16(+) subpopulations had a higher expression of HLA-DR, CD86, CD54 and a lower expression of CD64 than CD14(high) CD16(-) population. In addition, CD14(high) CD16(+) MO showed a higher expression of CD11b and TLR4 than CD14(dim) CD16(+) and CD14(high) CD16(-) subpopulations. CD14(high) CD16(+) MO exhibited an increased phagocytic activity and a decreased antigen presentation in comparison with CD14(dim) CD16(+). As expected, lipopolysaccharide (LPS)-stimulated CD14(dim) CD16(+) MO produced TNF-alpha but little IL-10. By contrast, LPS-stimulated CD14(high) CD16(+) subpopulation produced significantly more IL-10 than CD14(dim) CD16(+) and CD14(high) CD16(-) MO. In conclusion, our data show that human peripheral blood CD16(+) MO are heterogeneous in function and consist of two subpopulations: CD14(dim) CD16(+) pro-inflammatory and CD14(high) CD16(+) with anti-inflammatory potential.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201370     DOI: 10.1111/j.1365-3083.2007.02051.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  112 in total

1.  Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes.

Authors:  Silvano Garibaldi; Chiara Barisione; Giorgio Ghigliotti; Paolo Spallarossa; Antonio Barsotti; Patrizia Fabbi; Luca Corsiglia; Daniela Palmieri; Domenico Palombo; Claudio Brunelli
Journal:  Mol Biol Rep       Date:  2012-02-05       Impact factor: 2.316

Review 2.  The multiple roles of monocyte subsets in steady state and inflammation.

Authors:  Clinton S Robbins; Filip K Swirski
Journal:  Cell Mol Life Sci       Date:  2010-05-01       Impact factor: 9.261

3.  The impact of acute strenuous exercise on TLR2, TLR4 and HLA.DR expression on human blood monocytes induced by autologous serum.

Authors:  Stephen Booth; Geraint D Florida-James; Brian K McFarlin; Guillaume Spielmann; Daniel P O'Connor; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2010-08-27       Impact factor: 3.078

4.  Changes of monocyte subsets in patients with acute coronary syndrome and correlation with myocardial injury markers.

Authors:  Li Zhu; Yigang Yin; Ruifang Zhou; Jie Lin; Jianming Li; Jun Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.

Authors:  Lucie M Turcotte; Qing Cao; Sarah A Cooley; Julie Curtsinger; Shernan G Holtan; Xianghua Luo; Ashely Yingst; Daniel J Weisdorf; Bruce R Blazar; Jeffrey S Miller; John E Wagner; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2019-01-06       Impact factor: 5.742

6.  Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity.

Authors:  Rahul Chavan; Daniela Salvador; Michael P Gustafson; Allan B Dietz; Wendy Nevala; Svetomir N Markovic
Journal:  Cancer Immunol Res       Date:  2013-11-18       Impact factor: 11.151

7.  Monocytes and Macrophages in Heart Valves: Uninvited Guests or Critical Performers?

Authors:  Sridhar Sraeyes; Duc H Pham; Terence W Gee; Joanna Hua; Jonathan T Butcher
Journal:  Curr Opin Biomed Eng       Date:  2018-03-05

8.  Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.

Authors:  Delgertsetseg Chuluundorj; Scott A Harding; David Abernethy; Anne Camille La Flamme
Journal:  Immunol Cell Biol       Date:  2016-10-03       Impact factor: 5.126

9.  CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.

Authors:  Baoying Liu; Ashwin Dhanda; Sima Hirani; Emily L Williams; H Nida Sen; Fernando Martinez Estrada; Diamond Ling; Ian Thompson; Megan Casady; Zhiyu Li; Han Si; William Tucker; Lai Wei; Shayma Jawad; Amol Sura; Jennifer Dailey; Susan Hannes; Ping Chen; Jason L Chien; Siamon Gordon; Richard W J Lee; Robert B Nussenblatt
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

Review 10.  Making a difference: monocyte heterogeneity in cardiovascular disease.

Authors:  Ingo Hilgendorf; Filip K Swirski
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.